H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
FRA:2HRA - Deutsche Boerse Ag - DE000A2E4T77 - Common Stock - Currency: EUR
2HRA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 61 industry peers in the Chemicals industry. 2HRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 2HRA has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year 2HRA was profitable.
2HRA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 2HRA reported negative net income in multiple years.
In the past 5 years 2HRA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 2HRA (0.59%) is comparable to the rest of the industry.
2HRA's Return On Equity of 1.31% is in line compared to the rest of the industry. 2HRA outperforms 50.79% of its industry peers.
2HRA has a Return On Invested Capital (2.58%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 2HRA is in line with the industry average of 6.72%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.31% | ||
| ROIC | 2.58% |
ROA(3y)3.78%
ROA(5y)1.99%
ROE(3y)8.83%
ROE(5y)4.62%
ROIC(3y)6.18%
ROIC(5y)4.04%
1.3 Margins
With a Profit Margin value of 0.42%, 2HRA perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
In the last couple of years the Profit Margin of 2HRA has declined.
2HRA has a Operating Margin of 2.03%. This is comparable to the rest of the industry: 2HRA outperforms 53.97% of its industry peers.
2HRA's Operating Margin has declined in the last couple of years.
2HRA has a worse Gross Margin (23.12%) than 60.32% of its industry peers.
In the last couple of years the Gross Margin of 2HRA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.03% | ||
| PM (TTM) | 0.42% | ||
| GM | 23.12% |
OM growth 3Y62.81%
OM growth 5Y-5.94%
PM growth 3YN/A
PM growth 5Y-16.63%
GM growth 3Y-3.05%
GM growth 5Y0%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 2HRA is still creating some value.
2HRA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for 2HRA remains at a similar level compared to 5 years ago.
2HRA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.32 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
2HRA has a Altman-Z score of 2.32. This is comparable to the rest of the industry: 2HRA outperforms 58.73% of its industry peers.
2HRA has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as 2HRA would need 7.39 years to pay back of all of its debts.
The Debt to FCF ratio of 2HRA (7.39) is better than 68.25% of its industry peers.
2HRA has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
2HRA's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. 2HRA outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 7.39 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.49
WACC5.28%
2.3 Liquidity
A Current Ratio of 1.69 indicates that 2HRA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.69, 2HRA perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
2HRA has a Quick Ratio of 1.69. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
2HRA has a Quick ratio of 0.97. This is comparable to the rest of the industry: 2HRA outperforms 41.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
The earnings per share for 2HRA have decreased strongly by -60.76% in the last year.
The earnings per share for 2HRA have been decreasing by -13.49% on average. This is quite bad
The Revenue has decreased by -4.27% in the past year.
Measured over the past years, 2HRA shows a small growth in Revenue. The Revenue has been growing by 3.95% on average per year.
EPS 1Y (TTM)-60.76%
EPS 3YN/A
EPS 5Y-13.49%
EPS Q2Q%-55%
Revenue 1Y (TTM)-4.27%
Revenue growth 3Y15.7%
Revenue growth 5Y3.95%
Sales Q2Q%0.24%
3.2 Future
The Earnings Per Share is expected to grow by 7.72% on average over the next years.
The Revenue is expected to decrease by -0.53% on average over the next years.
EPS Next Y-54.55%
EPS Next 2Y-8.92%
EPS Next 3Y7.72%
EPS Next 5YN/A
Revenue Next Year-6.53%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.53%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.57, 2HRA can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 2HRA is valued a bit cheaper than 61.90% of the companies in the same industry.
2HRA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.74, the valuation of 2HRA can be described as very reasonable.
Based on the Price/Forward Earnings ratio, 2HRA is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.10. 2HRA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.57 | ||
| Fwd PE | 10.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 2HRA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2HRA indicates a rather cheap valuation: 2HRA is cheaper than 92.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.87 | ||
| EV/EBITDA | 2.22 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.92%
EPS Next 3Y7.72%
5. Dividend
5.1 Amount
2HRA has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, 2HRA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
The dividend of 2HRA decreases each year by -29.82%.
Dividend Growth(5Y)-29.82%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
67.35% of the earnings are spent on dividend by 2HRA. This is not a sustainable payout ratio.
DP67.35%
EPS Next 2Y-8.92%
EPS Next 3Y7.72%
FRA:2HRA (3/7/2025, 7:00:00 PM)
4
0 (0%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners1.39%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap148.88M
Analysts80
Price Target6.43 (60.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.1
Dividend Growth(5Y)-29.82%
DP67.35%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-47.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.57 | ||
| Fwd PE | 10.74 | ||
| P/S | 0.11 | ||
| P/FCF | 6.87 | ||
| P/OCF | 2.09 | ||
| P/B | 0.35 | ||
| P/tB | 0.38 | ||
| EV/EBITDA | 2.22 |
EPS(TTM)0.14
EY3.5%
EPS(NY)0.37
Fwd EY9.31%
FCF(TTM)0.58
FCFY14.55%
OCF(TTM)1.91
OCFY47.81%
SpS35.71
BVpS11.31
TBVpS10.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.31% | ||
| ROCE | 4% | ||
| ROIC | 2.58% | ||
| ROICexc | 2.99% | ||
| ROICexgc | 3.14% | ||
| OM | 2.03% | ||
| PM (TTM) | 0.42% | ||
| GM | 23.12% | ||
| FCFM | 1.63% |
ROA(3y)3.78%
ROA(5y)1.99%
ROE(3y)8.83%
ROE(5y)4.62%
ROIC(3y)6.18%
ROIC(5y)4.04%
ROICexc(3y)6.77%
ROICexc(5y)4.47%
ROICexgc(3y)7.16%
ROICexgc(5y)4.74%
ROCE(3y)9.55%
ROCE(5y)6.25%
ROICexcg growth 3Y66.93%
ROICexcg growth 5Y-6.83%
ROICexc growth 3Y68.14%
ROICexc growth 5Y-6.27%
OM growth 3Y62.81%
OM growth 5Y-5.94%
PM growth 3YN/A
PM growth 5Y-16.63%
GM growth 3Y-3.05%
GM growth 5Y0%
F-Score5
Asset Turnover1.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 7.39 | ||
| Debt/EBITDA | 0.96 | ||
| Cap/Depr | 75.97% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 2.82 | ||
| Cash Conversion | 77.2% | ||
| Profit Quality | 391.93% | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.28%
ROIC/WACC0.49
Cap/Depr(3y)104.36%
Cap/Depr(5y)108.93%
Cap/Sales(3y)4.28%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.76%
EPS 3YN/A
EPS 5Y-13.49%
EPS Q2Q%-55%
EPS Next Y-54.55%
EPS Next 2Y-8.92%
EPS Next 3Y7.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.27%
Revenue growth 3Y15.7%
Revenue growth 5Y3.95%
Sales Q2Q%0.24%
Revenue Next Year-6.53%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.53%
Revenue Next 5YN/A
EBIT growth 1Y-13.44%
EBIT growth 3Y88.37%
EBIT growth 5Y-2.23%
EBIT Next Year168.42%
EBIT Next 3Y45.22%
EBIT Next 5YN/A
FCF growth 1Y147.58%
FCF growth 3Y41.02%
FCF growth 5YN/A
OCF growth 1Y363.84%
OCF growth 3Y25.56%
OCF growth 5Y38.55%